The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Metal-associated amyloid-β species in Alzheimer's disease
Abstract
Highly concentrated metals such as Cu, Zn, and Fe are found in amyloid-β (Aβ) plaques within the brain of Alzheimer's disease (AD). In vitro and in vivo studies have suggested that metal binding to Aβ could facilitate Aβ aggregation and generate reactive oxygen species (ROS), which could contribute to the neuropathogenesis of AD. The connection between metal-Aβ interaction/reactivity and AD development, however, has not been clearly revealed owing to the complexity of the disease. In this review, metal-Aβ interaction/reactivity and its relation to neurotoxicity are briefly discussed. Additionally, our review illustrates the recent progress of small molecules, capable of targeting metal-Aβ species and modulating their interaction/reactivity, which could offer a promising approach to interrogate their role in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent efforts to control abnormal Aβ–metal interactions have focused on small molecules, bifunctional chelators (BFCs), that have binding affinity for both metal ions and Aβ aggregates.20,25,27−30”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [29]
Citations
Cites
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447
Alzheimer's Disease: From Pathology to Therapeutic Approaches
Jakob‐Roetne, R., & Jacobsen, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802808 · Cited by 626
The redox chemistry of the Alzheimer's disease amyloid β peptide
Smith, D. G., Cappai, R., & Barnham, K. J. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.02.002 · Cited by 608
Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-β peptide
Faller, P., & Hureau, C. (2009) · Dalton Trans. · doi:10.1039/b813398k · Cited by 530
The chemistry of Alzheimer’s disease
Rauk, A. (2009) · Chemical Society Reviews · doi:10.1039/b807980n · Cited by 417
Alzheimer's disease, metal ions and metal homeostatic therapy
Zatta, P., Drago, D., Bolognin, S., & Sensi, S. L. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.05.002 · Cited by 369
Causes of oxidative stress in Alzheimer disease
Zhu, X., Su, B., Wang, X., Smith, M. A., & Perry, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7218-4 · Cited by 336
Scott, L. E., & Orvig, C. (2009) · Chemical Reviews · doi:10.1021/cr9000176 · Cited by 332
Choi, J.-S., Braymer, J. J., Nanga, R. P. R., Ramamoorthy, A., & Lim, M. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006091107 · Cited by 264
Self-citationHureau, C., & Faller, P. (2009) · Biochimie · doi:10.1016/j.biochi.2009.03.013 · Cited by 259
Minding metals: Tailoring multifunctional chelating agents for neurodegenerative disease
Perez, L. R., & Franz, K. J. (2010) · Dalton Trans. · doi:10.1039/b919237a · Cited by 156
Braymer, J. J., DeToma, A. S., Choi, J.-S., Ko, K. S., & Lim, M. H. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/623051 · Cited by 50
Self-citationTwo Functions, One Molecule: A Metal‐Binding and a Targeting Moiety to Combat Alzheimer's Disease
Hureau, C., Sasaki, I., Gras, E., & Faller, P. (2010) · ChemBioChem · doi:10.1002/cbic.201000102 · Cited by 49
Flagged first, then by citations
Research works printed but not linked: 31
- Alzheimer's Association, 2011, Alzheimer's disease facts and figures, Alzheimers Dement, 7, 208, 10.1016/j.jalz.2011.02.004 · DOI
- Hardy, 1992, Alzheimer's disease: the amyloid cascade hypothesis, Science, 256, 184, 10.1126/science.1566067 · DOI · Paper page
- Wang, 2006, Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives, Drug Discov Today, 11, 931, 10.1016/j.drudis.2006.08.004 · DOI
- Kurz, 2011, Amyloid clearance as a treatment target against Alzheimer's disease, J Alzheimers Dis, 24, 61, 10.3233/JAD-2011-102139 · DOI
- Maynard, 2005, Metals and amyloid-β in Alzheimer's disease, Int J Exp Pathol, 86, 147, 10.1111/j.0959-9673.2005.00434.x · DOI
- Bonda, 2011, Role of metal dyshomeostasis in Alzheimer's disease, Metallomics, 3, 267, 10.1039/c0mt00074d · DOI
- Jomova, 2011, Advances in metal-induced oxidative stress and human diseases, Toxicology, 283, 65, 10.1016/j.tox.2011.03.001 · DOI
- DeToma, 2012, Misfolded proteins in Alzheimer's disease and type II diabetes, Chem Soc Rev, 41, 608, 10.1039/C1CS15112F · DOI
- Burdette, 2003, Meeting of the minds: metalloneurochemistry, Proc Natl Acad Sci USA, 100, 3605, 10.1073/pnas.0637711100 · DOI
- Que, 2008, Metals in neurobiology: probing their chemistry and biology with molecular imaging, Chem Rev, 108, 1517, 10.1021/cr078203u · DOI
- Bush, 2008, Therapeutics for Alzheimer's disease based on the metal hypothesis, Neurotherapeutics, 5, 421, 10.1016/j.nurt.2008.05.001 · DOI
- Frederickson, 2005, The neurobiology of zinc in health and disease, Nat Rev Neurosci, 6, 449, 10.1038/nrn1671 · DOI
- Faller, 2009, Copper and zinc binding to amyloid-β: coordination, dynamics, aggregation, reactivity and metal-ion transfer, ChemBioChem, 10, 2837, 10.1002/cbic.200900321 · DOI · Paper page
- Gaggelli, 2006, Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyothrophic lateral sclerosis), Chem Rev, 106, 1995, 10.1021/cr040410w · DOI · Paper page
- Drew, 2011, The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide, Acc Chem Res, 44, 1146, 10.1021/ar200014u · DOI
- Karr, 2008, Cu(II) binding to monomeric, oligomeric, and fibrillar forms of the Alzheimer's disease amyloid-β peptide, Biochemistry, 47, 5006, 10.1021/bi702423h · DOI
- Dorlet, 2009, Pulse EPR spectroscopy reveals the coordination sphere of copper(II) ions in the 1–16 amyloid-β peptide: a key role of the first two N-terminus residues, Angew Chem Int Ed, 48, 9273, 10.1002/anie.200904567 · DOI
- Shearer, 2008, The amyloid-β peptide of Alzheimer's disease binds CuI in a linear bis-His coordination environment: insight into a possible neuroprotective mechanism for the amyloid-β peptide, J Am Chem Soc, 130, 17826, 10.1021/ja805940m · DOI
- Himes, 2008, Structural studies of copper(I) complexes of amyloid-β peptide fragments: formation of two-coordinate bis(histidine) complexes, Angew Chem Int Ed, 47, 9084, 10.1002/anie.200803908 · DOI
- Shearer, 2010, Cu K-edge X-ray absorption spectroscopy reveals differential copper coordination within amyloid-β oligomers compared to amyloid-β monomers, Chem Commun, 46, 9137, 10.1039/c0cc02446e · DOI
- Feaga, 2011, Affinity of Cu+ for the copper-binding domain of amyloid-β peptide of Alzheimer's disease, Inorg Chem, 50, 1614, 10.1021/ic100967s · DOI
- Bousejra-ElGarah, 2011, Iron(II) binding to amyloid-β, the Alzheimer's peptide, Inorg Chem, 50, 9024, 10.1021/ic201233b · DOI
- Noy, 2008, Zinc-amyloid β interactions on a millisecond time-scale stabilize non-fibrillar Alzheimer-related species, J Am Chem Soc, 130, 1376, 10.1021/ja076282l · DOI
- Chen, 2011, Distinct effects of Zn2+, Cu2+, Fe3+, and Al3+ on amyloid-β stability, oligomerization, and aggregation, J Biol Chem, 286, 9646, 10.1074/jbc.M110.177246 · DOI
- Pramanik, 2011, Active site environment of heme-bound amyloid β peptide associated with Alzheimer's disease, J Am Chem Soc, 133, 81, 10.1021/ja1084578 · DOI
- Atamna, 2006, Amyloid-β peptide binds with heme to form a peroxidase: relationship to the cytopathologies of Alzheimer's disease, Proc Natl Acad Sci USA, 103, 3381, 10.1073/pnas.0600134103 · DOI
- Atamna, 2006, Heme binding to amyloid β peptide: mechanistic role in Alzheimer's disease, J Alzheimers Dis, 10, 255, 10.3233/JAD-2006-102-310 · DOI
- Adlard, 2008, Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ, Neuron, 59, 43, 10.1016/j.neuron.2008.06.018 · DOI · Paper page
- Kung, 2001, Novel stilbenes as probes for amyloid plaques, J Am Chem Soc, 123, 12740, 10.1021/ja0167147 · DOI
- Ono, 2004, Curcumin has potent anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro, J Neurosci Res, 75, 742, 10.1002/jnr.20025 · DOI · Paper page
- Wu, 2008, Sequestration of copper from β-amyloid promotes selective lysis by cyclen-hybrid cleave agents, J Biol Chem, 283, 31657, 10.1074/jbc.M804722200 · DOI
Cited by
Sorted by citations
Exploration of the medical periodic table: towards new targets
Barry, N. P. E., & Sadler, P. J. (2013) · Chemical Communications · doi:10.1039/c3cc41143e · Cited by 720
Amyloid β Protein and Alzheimer’s Disease: When Computer Simulations Complement Experimental Studies
Nasica-Labouze, J., Nguyen, P. H., Sterpone, F., Berthoumieu, O., Buchete, N., Côté, S., Simone, A. D., Doig, A. J., Faller, P., García, A. E., et al. (2015) · Chemical Reviews · doi:10.1021/cr500638n · Cited by 591
Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 612
Self-citationUntangling Amyloid-β, Tau, and Metals in Alzheimer’s Disease
Savelieff, M. G., Lee, S., Liu, Y., & Lim, M. H. (2013) · ACS Chemical Biology · doi:10.1021/cb400080f · Cited by 407
Self-citationRole of Metal Ions in the Self-assembly of the Alzheimer’s Amyloid-β Peptide
Faller, P., Hureau, C., & Berthoumieu, O. (2013) · Inorganic Chemistry · doi:10.1021/ic4003059 · Cited by 360
Metadata
- Authors
- Pithadia, A. S., & Lim, M. H.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Lim, Mi Hee
- ORCID
- Lim, Mi Hee
- Venue
- Current Opinion in Chemical Biology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 16
- Issue
- 1-2
- Pages
- 67-73
- ISSN
- 1367-5931 (ISSN-L)
- OpenAlex
- W1984223653
- Cited by
- 259
- References
- 48
- Citations by year
- 2026: 3 · 2025: 12 · 2024: 10 · 2023: 14 · 2022: 11 · 2021: 17 · 2020: 21 · 2019: 28 · 2018: 30 · 2017: 25 · 2016: 16 · 2015: 18 · 2014: 26 · 2013: 20 · 2012: 8
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- Scholarworks@UNIST (Ulsan National Institute of Science and Technology) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Aluminum toxicity and tolerance in plants and animals
- Keywords
- Alzheimer's disease, amyloid-beta, metal ion binding, copper, zinc, iron, amyloid plaques, amyloid-beta aggregation, reactive oxygen species, neurotoxicity, metal chelators
- MeSH terms
- Alzheimer Disease, Amyloid, Humans, Metals, Reactive Oxygen Species
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review